NCT02157012招募中4 期
Evaluation of the Condition After Xeljanz Treatment in Rheumatoid Arthritis Patients
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Change from baseline of clinical evaluation in rheumatoid arthritis
研究概览
简要总结
To examine the safety and effectiveness after Xeljanz treatment in rheumatoid arthritis patients
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 20 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Rheumatoid arthritis
排除标准
- •Other connective tissue disease
研究组 & 干预措施
The condition of rheumatoid arthritis
Experimental
干预措施: The effectiveness of Xeljanz in rheumatoid arthritis patients (Drug)
结局指标
主要结局
Change from baseline of clinical evaluation in rheumatoid arthritis
时间窗: Every month
DAS28, SDAI, Blood testing, Plain radiograph, and Ultrasound will be performed.
次要结局
- Number of participants with adverse events(Every month)
研究者
Yukio Nakamura
Assistant Professor
Shinshu University
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic ArthritisPsoriatic Arthritis, JuvenilePolyarticular Juvenile Idiopathic ArthritisNCT05754710Pfizer10
已完成
不适用
Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in SpainArthritis, PsoriaticArthritis, RheumatoidNCT00195377Wyeth is now a wholly owned subsidiary of Pfizer1,000
已完成
不适用
Xeljanz Special Investigation for Long-term Use in UC PatientsUlcerative ColitisNCT03643211Pfizer2,016
终止
1 期
Safety, Pharmacodynamics and Pharmacokinetics of GSK2136525 Repeat Dose in Rheumatoid ArthritisArthritis, RheumatoidNCT01077531GlaxoSmithKline12
招募中
不适用
An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With RA and ASRheumatoid ArthritisAnkylosing SpondylitisNCT05835518Yuhan Corporation1,000